These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 31822352)

  • 41. Multi-chassis engineering for heterologous production of microbial natural products.
    Ke J; Yoshikuni Y
    Curr Opin Biotechnol; 2020 Apr; 62():88-97. PubMed ID: 31639618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct Capture Technologies for Genomics-Guided Discovery of Natural Products.
    Chan AN; Santa Maria KC; Li B
    Curr Top Med Chem; 2016; 16(15):1695-704. PubMed ID: 26456469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural Products from Mammalian Gut Microbiota.
    Wang L; Ravichandran V; Yin Y; Yin J; Zhang Y
    Trends Biotechnol; 2019 May; 37(5):492-504. PubMed ID: 30392727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Thiotetronic Acid Antibiotic Biosynthetic Pathways by Target-directed Genome Mining.
    Tang X; Li J; Millán-Aguiñaga N; Zhang JJ; O'Neill EC; Ugalde JA; Jensen PR; Mantovani SM; Moore BS
    ACS Chem Biol; 2015 Dec; 10(12):2841-2849. PubMed ID: 26458099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery.
    Wolfender JL; Litaudon M; Touboul D; Queiroz EF
    Nat Prod Rep; 2019 Jun; 36(6):855-868. PubMed ID: 31073562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Use of ClusterMine360 for the Analysis of Polyketide and Nonribosomal Peptide Biosynthetic Pathways.
    Tremblay N; Hill P; Conway KR; Boddy CN
    Methods Mol Biol; 2016; 1401():233-52. PubMed ID: 26831712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breaking the silence: new strategies for discovering novel natural products.
    Ren H; Wang B; Zhao H
    Curr Opin Biotechnol; 2017 Dec; 48():21-27. PubMed ID: 28288336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.
    Xie P; Ma M; Rateb ME; Shaaban KA; Yu Z; Huang SX; Zhao LX; Zhu X; Yan Y; Peterson RM; Lohman JR; Yang D; Yin M; Rudolf JD; Jiang Y; Duan Y; Shen B
    J Nat Prod; 2014 Feb; 77(2):377-87. PubMed ID: 24484381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of caerulomycin/collismycin-type 2,2'-bipyridine natural products in the genomic era.
    Chen D; Zhao Q; Liu W
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):459-468. PubMed ID: 30484122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudo-natural products and natural product-inspired methods in chemical biology and drug discovery.
    Grigalunas M; Burhop A; Christoforow A; Waldmann H
    Curr Opin Chem Biol; 2020 Jun; 56():111-118. PubMed ID: 32362382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nerpa: A Tool for Discovering Biosynthetic Gene Clusters of Bacterial Nonribosomal Peptides.
    Kunyavskaya O; Tagirdzhanov AM; Caraballo-Rodríguez AM; Nothias LF; Dorrestein PC; Korobeynikov A; Mohimani H; Gurevich A
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Culture-independent discovery of natural products from soil metagenomes.
    Katz M; Hover BM; Brady SF
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):129-41. PubMed ID: 26586404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New voyages to explore the natural product galaxy.
    Mouncey NJ; Otani H; Udwary D; Yoshikuni Y
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):273-279. PubMed ID: 30610411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterologous expression of bacterial natural product biosynthetic pathways.
    Huo L; Hug JJ; Fu C; Bian X; Zhang Y; Müller R
    Nat Prod Rep; 2019 Oct; 36(10):1412-1436. PubMed ID: 30620035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New strategies and approaches for engineering biosynthetic gene clusters of microbial natural products.
    Li L; Jiang W; Lu Y
    Biotechnol Adv; 2017 Dec; 35(8):936-949. PubMed ID: 28323062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mining and unearthing hidden biosynthetic potential.
    Scherlach K; Hertweck C
    Nat Commun; 2021 Jun; 12(1):3864. PubMed ID: 34162873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioactive Secondary Metabolites from Octocoral-Associated Microbes-New Chances for Blue Growth.
    Raimundo I; Silva SG; Costa R; Keller-Costa T
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30518125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanding our understanding of sequence-function relationships of type II polyketide biosynthetic gene clusters: bioinformatics-guided identification of Frankiamicin A from Frankia sp. EAN1pec.
    Ogasawara Y; Yackley BJ; Greenberg JA; Rogelj S; Melançon CE
    PLoS One; 2015; 10(4):e0121505. PubMed ID: 25837682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery.
    Rigali S; Anderssen S; Naômé A; van Wezel GP
    Biochem Pharmacol; 2018 Jul; 153():24-34. PubMed ID: 29309762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Something old, something new: revisiting natural products in antibiotic drug discovery.
    Wright GD
    Can J Microbiol; 2014 Mar; 60(3):147-54. PubMed ID: 24588388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.